Enhancing Mitochondrial Respiration Suppresses Tumor Promoter TPA-Induced PKM2 Expression and Cell Transformation in Skin Epidermal JB6 Cells

Differentiated cells primarily metabolize glucose for energy via the tricarboxylic acid cycle and oxidative phosphorylation, but cancer cells thrive on a different mechanism to produce energy, characterized as the Warburg effect, which describes the increased dependence on aerobic glycolysis. The M2 isoform of pyruvate kinase (PKM2), which is responsible for catalyzing the final step of aerobic glycolysis, is highly expressed in cancer cells and may contribute to the Warburg effect. However, whether PKM2 plays a contributing role during early cancer development is unclear. In our studies, we have made an attempt to elucidate the effects of varying mitochondrial respiration substrates on skin cell transformation and expression of PKM2. Tumorigenicity in murine skin epidermal JB6 P+ (promotable) cells was measured in a soft agar assay using 12-O-tetradecanoylphorbol-13-acetate (TPA) as a tumor promoter. We observed a significant reduction in cell transformation upon pretreatment with the mitochondrial respiration substrate succinate or malate/pyruvate. We observed that increased expression and activity of PKM2 in TPA-treated JB6 P+ cells and pretreatment with succinate or malate/pyruvate suppressed the effects. In addition, TPA treatment also induced PKM2 whereas PKM1 expression was suppressed in mouse skin epidermal tissues in vivo. In comparison with JB6 P+ cells, the nonpromotable JB6 P− cells showed no increase in PKM2 expression or activity upon TPA treatment. Knockdown of PKM2 using a siRNA approach significantly reduced skin cell transformation. Thus, our results suggest that PKM2 activation could be an early event and play a contributing role in skin tumorigenesis. Cancer Prev Res; 4(9); 1476–84. ©2011 AACR.

[1]  R. Beitner.  Regulation Of Carbohydrate Metabolism , 2018 .

[2]  Yunfeng Zhao,et al.  Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells , 2011, Apoptosis.

[3]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[4]  J. Manley,et al.  Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. , 2010, Cancer research.

[5]  B. Kefas,et al.  Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells. , 2010, Neuro-oncology.

[6]  Jason W. Locasale,et al.  Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells , 2010, Science.

[7]  O. Gofrit,et al.  Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy. , 2010, Urology.

[8]  Fei Wang,et al.  The Chemopreventive Effects of Protandim: Modulation of p53 Mitochondrial Translocation and Apoptosis during Skin Carcinogenesis , 2010, PloS one.

[9]  Yuquan Wei,et al.  Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice , 2010, Cancer science.

[10]  Agnieszka K Witkiewicz,et al.  The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts , 2010, Cell cycle.

[11]  Mélanie Schmidt,et al.  The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer. , 2010, Anticancer research.

[12]  H. Christofk,et al.  Identification of small molecule inhibitors of pyruvate kinase M2. , 2010, Biochemical pharmacology.

[13]  T. Heusner,et al.  Tumor-specific correlation of tumor M2 pyruvate kinase in pre-invasive, invasive and recurrent cervical cancer. , 2010, Anticancer research.

[14]  M. Assanah,et al.  HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer , 2010, Nature.

[15]  A. Krainer,et al.  The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism , 2010, Proceedings of the National Academy of Sciences.

[16]  B. Zhivotovsky,et al.  The Warburg Effect returns to the cancer stage. , 2009, Seminars in cancer biology.

[17]  J. Rathmell,et al.  New roles for pyruvate kinase M2: working out the Warburg effect. , 2008, Trends in biochemical sciences.

[18]  D. S. St. Clair,et al.  Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion , 2008, FEBS letters.

[19]  M. López-Lázaro,et al.  The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? , 2008, Anti-cancer agents in medicinal chemistry.

[20]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[21]  T. Aw,et al.  Contribution of mitochondrial GSH transport to matrix GSH status and colonic epithelial cell apoptosis. , 2008, Free radical biology & medicine.

[22]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[23]  Peng Huang,et al.  The Warburg effect and its cancer therapeutic implications , 2007, Journal of bioenergetics and biomembranes.

[24]  Emma Saavedra,et al.  Energy metabolism in tumor cells , 2007, The FEBS journal.

[25]  M. Mattson,et al.  Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions. , 2006, Free radical biology & medicine.

[26]  C. Boschek,et al.  Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.

[27]  A. Mesecar,et al.  Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. , 2005, Biochemistry.

[28]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[29]  W. Zwerschke,et al.  Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7 , 2001, Oncogene.

[30]  C. Epstein,et al.  Strain-dependent high-level expression of a transgene for manganese superoxide dismutase is associated with growth retardation and decreased fertility. , 2001, Free radical biology & medicine.

[31]  W. Zwerschke,et al.  Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex. , 2001, The Biochemical journal.

[32]  F. Oesch,et al.  Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats , 1999, Virchows Archiv.

[33]  L. Banks,et al.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Danielewicz,et al.  Interaction of M1 and M2 isozymes pyruvate kinase from human tissues with phospholipids. , 1998, Biochimica et biophysica acta.

[35]  B. Stoddard,et al.  The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. , 1998, Structure.

[36]  C. Boschek,et al.  The Role of Phosphometabolites in Cell Proliferation, Energy Metabolism, and Tumor Therapy , 1997, Journal of bioenergetics and biomembranes.

[37]  M. Willingham,et al.  In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. , 1991, The Journal of biological chemistry.

[38]  T. Tanaka,et al.  The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. , 1987, The Journal of biological chemistry.

[39]  T. Tanaka,et al.  The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. , 1986, The Journal of biological chemistry.

[40]  T. Tanaka,et al.  Crystallization, characterization and metabolic regulation of two types of pyruvate kinase isolated from rat tissues. , 1967, Journal of biochemistry.

[41]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[42]  Jaw-Yuan Wang,et al.  Significance of the glycolytic pathway and glycolysis related-genes in tumorigenesis of human colorectal cancers. , 2008, Oncology reports.

[43]  D. S. St. Clair,et al.  Detection of the content and activity of the transcription factor AP-1 in a multistage skin carcinogenesis model. , 2003, Methods in molecular biology.

[44]  P. Huppert,et al.  Expression of hypoxia-inducible genes in tumor cells , 1998, Journal of Cancer Research and Clinical Oncology.

[45]  P. Steinberg,et al.  Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. , 1998, Carcinogenesis.

[46]  E. Eigenbrodt,et al.  Chapter 10 – Carbohydrate Metabolism and Neoplasia: New Perspectives for Diagnosis and Therapy , 1994 .

[47]  E. Eigenbrodt,et al.  [Immunohistologic photometric quantification of pyruvate kinase content of rat tumors]. , 1990, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[48]  M. Gumińska,et al.  The inhibitory effect of various fatty acids on aerobic glycolysis in Ehrlich ascites tumour cells. , 1986, Acta biochimica Polonica.

[49]  G. Valentini,et al.  AMP- and fructose 1,6-bisphosphate-activated pyruvate kinases from Escherichia coli. , 1982, Methods in enzymology.

[50]  E. Eigenbrodt,et al.  Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-Pk) in tumors of chicken and rat , 1981, Virchows Archiv. B, Cell pathology including molecular pathology.